CT引导同步冷冻活检与微波消融治疗高危亚实性结节的诊断结局与安全性
该多中心回顾性研究纳入198例高危肺亚实性结节患者,比较冷冻活检、细针穿刺(FNA)及两者联合活检在CT引导同步微波消融中的诊断率和安全性。结果显示三组技术成功率均100%,总诊断率80.3%,冷冻活检组(85.7%)和联合组(92.9%)高于FNA组(77.2%),但差异无统计学意义(p=0.129)。冷冻活检和联合组肺出血及咯血发生率显著高于FNA组,所有不良事件均为1-2级,无≥3级事件。
要点
- 冷冻活检(单独或联合FNA)诊断率数值上高于FNA,但差异未达统计学显著(p=0.129)。
- 冷冻活检和联合组肺出血(38.1%、39.3% vs 14.1%)及咯血(14.3%、21.4% vs 4.0%)显著高于FNA组。
- 所有不良事件均为1-2级,无≥3级事件;气胸发生率16-19%,组间无显著差异。
局限性
- 回顾性研究设计
- 冷冻活检组和联合组样本量较小(分别为21例和28例)
- 诊断率组间差异未达统计学显著
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the feasibility, safety, and diagnostic yield of CT-guided synchronous cryobiopsy and microwave ablation (MWA) for high-risk pulmonary subsolid nodules (SSNs).
MATERIALS AND METHODS: A retrospective review was conducted of patients undergoing CT-guided synchronous cryobiopsy and MWA for high-risk SSNs at three institutions between January and December 2023. Patients were grouped by biopsy method (cryobiopsy alone, fine-needle aspiration [FNA] alone, or combined biopsy with both). The primary endpoint was diagnostic yield, defined as the rate of definitive pathological diagnosis. Secondary endpoints included technical success, technical efficacy, and 30-day adverse events.
RESULTS: A total of 198 patients (21 cryobiopsy, 149 FNA, 28 combined) were analyzed. Technical success was 100% in all groups. Overall diagnostic yield was 80.3% (159/198). Diagnostic yield was 85.7% for cryobiopsy, 77.2% for FNA, and 92.9% for combined biopsy. Cryobiopsy (alone or combined) improved diagnostic yield compared to FNA alone, though the difference was not statistically significant (p = 0.129). Multivariable logistic regression identified no independent predictors of diagnostic yield. The complete ablation reached 100% in both groups. No patients experienced local tumor progression during the follow-up period. All adverse events were grade 1-2; no grade ≥3 events occurred. Self-limited pulmonary hemorrhage (grade 1) was the most common adverse event. Pulmonary hemorrhage rates were significantly higher in the cryobiopsy and combined groups than in the FNA group (38.1% and 39.3% vs. 14.1%, p = 0.001). Similarly, hemoptysis was more frequent in cryobiopsy and combined groups (14.3% and 21.4% vs. 4.0%, p = 0.003). Pneumothorax occurred in 16-19% of patients across groups (4.8-14.3% requiring chest tube); pneumothorax rates did not differ significantly among groups.
CONCLUSION: CT-guided synchronous cryobiopsy with MWA is a feasible and safe approach for diagnosing and treating high-risk SSNs. Cryobiopsy, alone or combined with FNA, demonstrated a higher diagnostic yield for SSNs than FNA alone, supporting its use to improve pathological confirmation during ablation procedures.
引用
- Peng JZ, Liu C, Wang DD, et al. Diagnostic Outcomes and Safety of CT-guided Synchronous Cryobiopsy and Microwave Ablation for High-risk Subsolid Nodules. Acad Radiol. 2026. PMID: 41916802. doi:10.1016/j.acra.2026.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。